BrightSpring Health Services, Inc. (BTSG)
NASDAQ: BTSG · Real-Time Price · USD
21.31
+1.21 (6.02%)
At close: Jul 30, 2025, 4:00 PM
21.25
-0.06 (-0.28%)
After-hours: Jul 30, 2025, 6:39 PM EDT
BTSG Stock Forecast
Stock Price Forecast
The 9 analysts that cover BTSG stock have a consensus rating of "Strong Buy" and an average price target of $23.5, which forecasts a 10.28% increase in the stock price over the next year. The lowest target is $18 and the highest is $30.
Price Target: $23.5 (+10.28%)
Analyst Consensus: Strong Buy
* Price targets were last updated on May 13, 2025.
Analyst Ratings
The average analyst rating for BTSG stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 6 | 6 | 4 | 4 | 4 |
| Buy | 5 | 5 | 5 | 4 | 4 | 4 |
| Hold | 2 | 2 | 2 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 13 | 13 | 13 | 9 | 9 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Buy Maintains $25 → $27 | Buy | Maintains | $25 → $27 | +26.70% | May 13, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $20 → $25 | Buy | Maintains | $20 → $25 | +17.32% | May 9, 2025 |
| UBS | UBS | Strong Buy Maintains $22 → $30 | Strong Buy | Maintains | $22 → $30 | +40.78% | Jan 29, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $19 → $20 | Buy | Maintains | $19 → $20 | -6.15% | Dec 17, 2024 |
| CJS Securities | CJS Securities | Buy Initiates $27 | Buy | Initiates | $27 | +26.70% | Dec 12, 2024 |
Financial Forecast
Revenue This Year
12.60B
from 11.27B
Increased by 11.79%
Revenue Next Year
14.17B
from 12.60B
Increased by 12.50%
EPS This Year
0.86
from -0.09
EPS Next Year
1.07
from 0.86
Increased by 24.10%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 13.3B | 15.5B | 18.1B | ||
| Avg | 12.6B | 14.2B | 15.9B | ||
| Low | 12.0B | 13.0B | 14.0B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 18.1% | 23.2% | 28.0% | ||
| Avg | 11.8% | 12.5% | 11.9% | ||
| Low | 6.4% | 3.2% | -1.5% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 1.14 | 1.53 | 1.93 |
| Avg | 0.86 | 1.07 | 1.25 |
| Low | 0.47 | 0.69 | 0.87 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | 78.1% | 80.9% |
| Avg | - | 24.1% | 17.0% |
| Low | - | -20.3% | -18.3% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.